The number most prominently refers to BLA 125477 , the official Biologics License Application number for the FDA-approved drug Cyramza (ramucirumab) . Pharmaceutical Context (Cyramza)
: On platforms like X (formerly Twitter), @125477 (helldermatador) is a user handle. 125477Orig1s000 - accessdata.fda.gov 125477
: The original approval for gastric cancer occurred in April 2014 . Other References The number most prominently refers to BLA 125477